Heart, Lung and Circulation
Abstract| Volume 17, SUPPLEMENT 1, S20, 2008

Levosimendan in postcardiotomy heart failure

      Levosimendan is a new inodilator agent used in decompansated heart failure, acute coronary syndromes, postcardiotomy heart failure and difficulties weaning from cardiopulmonary bypass.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect